Literature DB >> 9618261

Osmotic stress in viable Escherichia coli as the basis for the antibiotic response by polymyxin B.

J T Oh1, T K Van Dyk, Y Cajal, P S Dhurjati, M Sasser, M K Jain.   

Abstract

Cationic antimicrobial peptides, such as polymyxin B (PxB), below growth inhibitory concentration induce expression of osmY gene in viable E. coli without leakage of solutes and protons. osmY expression is also a locus of hyperosmotic stress response induced by common food preservatives, such as hypertonic NaCl or sucrose. High selectivity of PxB against Gram-negative organisms and the basis for the hyperosmotic stress response at sublethal PxB concentrations is attributed to PxB-induced mixing of anionic phospholipid between the outer layer of the cytoplasmic membrane with phospholipids in the inner layer of the outer membrane. This explanation is supported by PxB-mediated rapid and direct exchange of anionic phospholipid between vesicles. This mechanism is consistent with the observation that genetically stable resistance against PxB could not be induced by mutagenesis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9618261     DOI: 10.1006/bbrc.1998.8682

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  15 in total

1.  Stress responses as a tool To detect and characterize the mode of action of antibacterial agents.

Authors:  A A Bianchi; F Baneyx
Journal:  Appl Environ Microbiol       Date:  1999-11       Impact factor: 4.792

2.  Global analysis of genes regulated by EvgA of the two-component regulatory system in Escherichia coli.

Authors:  Kunihiko Nishino; Yoshihiko Inazumi; Akihito Yamaguchi
Journal:  J Bacteriol       Date:  2003-04       Impact factor: 3.490

3.  Genome-wide transcriptional profiling of the Escherichia coli response to a proline-rich antimicrobial peptide.

Authors:  Linda Tomasinsig; Marco Scocchi; Romina Mettulio; Margherita Zanetti
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

4.  Resistance to antimicrobial peptides and stress response in Mycoplasma pulmonis.

Authors:  Lina Fassi Fehri; Pascal Sirand-Pugnet; Géraldine Gourgues; Gwenaël Jan; Henri Wróblewski; Alain Blanchard
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

5.  Polymyxin B induces lysis of marine pseudoalteromonads.

Authors:  Mart Krupovic; Rimantas Daugelavicius; Dennis H Bamford
Journal:  Antimicrob Agents Chemother       Date:  2007-08-20       Impact factor: 5.191

6.  Design, synthesis, and evaluation of a new fluorescent probe for measuring polymyxin-lipopolysaccharide binding interactions.

Authors:  Rachel L Soon; Tony Velkov; Francis Chiu; Philip E Thompson; Rashmi Kancharla; Kade Roberts; Ian Larson; Roger L Nation; Jian Li
Journal:  Anal Biochem       Date:  2010-11-02       Impact factor: 3.365

Review 7.  Polymyxin: Alternative Mechanisms of Action and Resistance.

Authors:  Michael J Trimble; Patrik Mlynárčik; Milan Kolář; Robert E W Hancock
Journal:  Cold Spring Harb Perspect Med       Date:  2016-10-03       Impact factor: 6.915

Review 8.  In Silico Discovery of Novel Ligands for Antimicrobial Lipopeptides for Computer-Aided Drug Design.

Authors:  Satya Eswari Jujjavarapu; Swasti Dhagat
Journal:  Probiotics Antimicrob Proteins       Date:  2018-06       Impact factor: 4.609

9.  Activity of cecropin A-melittin hybrid peptides against colistin-resistant clinical strains of Acinetobacter baumannii: molecular basis for the differential mechanisms of action.

Authors:  José María Saugar; María Jesús Rodríguez-Hernández; Beatriz G de la Torre; María Eugenia Pachón-Ibañez; María Fernández-Reyes; David Andreu; Jerónimo Pachón; Luis Rivas
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.191

10.  genetic determinants of intrinsic colistin tolerance in Acinetobacter baumannii.

Authors:  M Indriati Hood; Kyle W Becker; Christelle M Roux; Paul M Dunman; Eric P Skaar
Journal:  Infect Immun       Date:  2012-12-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.